🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The study will begin with a two-week lead-in period (W-2 and W-1), when par...
Status
Recruiting
Location
RDSS Research Center
Start Date
2023-07-20
Trial ID
NCT06676410
Treatments Being Tested
Study designed to observe the usage patterns, efficacy and safety of REKOVE...
Status
Completed
Location
Ferring Investigational Site
Start Date
2022-08-28
Trial ID
NCT05499052
Treatments Being Tested
The NeuMoDx EBV Quant Assay 2.0 study is a multi-center, observational clin...
Status
Completed
Location
QIAGEN Gaithersburg, Inc.
Start Date
2022-08-31
Trial ID
NCT06681025
Treatments Being Tested
This is a multicentre prospective study of the feasibility and clinical val...
Status
Active Not Recruiting
Location
John Hunter Children's Hospital
Start Date
2017-09-05
Trial ID
NCT03336931
Treatments Being Tested
Validation of ex vivo immune assays that are surrogates of complex in vitro...
Status
Unknown
Location
Multiple Locations
Start Date
2023-03
Trial ID
NCT05722054
Treatments Being Tested
Despite public campaigns to prevent cigarette smoking, it's about 20% of wo...
Status
Completed
Location
Inserm
Start Date
2017-11-10
Trial ID
NCT03047967
Treatments Being Tested
The goal of this performance study is to learn if treatment with neoadjuvan...
Status
Recruiting
Location
Allg. Gynäkologie u. gyn. Onkologie/Senologie
Start Date
2025-08-13
Trial ID
NCT07084558
The combination of azacitidine and venetoclax is currently considered a the...
Status
Recruiting
Location
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Start Date
2024-04-17
Trial ID
NCT06874257
Treatments Being Tested
This study evaluates the stability of 25-hydroxyvitamin D \[25(OH)D\] measu...
Status
Enrolling By Invitation
Location
ALPCO
Start Date
2026-04-18
Trial ID
NCT07565064
Treatments Being Tested
Hemolytic Uremic Syndrome (HUS) is a rare disease characterized by rupture ...
Status
Recruiting
Location
Centro di Ricerche Cliniche per le Malattie Rare "Aldo e Cele Daccò"
Start Date
2023-05-03
Trial ID
NCT05805202
Treatments Being Tested